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Abstract
Thermotherapy, as a method of treating cancer, has recently attracted considerable attention from
basic and clinical investigators. A number of studies and clinical trials have shown that
thermotherapy can be successfully used as a therapeutic approach for various cancers. However,
the effects of temperature on cancer bioenergetics have not been studied in detail with a real time,
in a microplate, label-free detection approach.
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This study investigate how changes in temperature affect the bioenergetics characteristics
(mitochondrial function and glycolysis) of three colorectal cancer (CRC) cell lines utilizing the
Seahorse XF96 technology. Experiments were performed at 32°C, 37°C and 42°C using assay
medium conditions and equipment settings adjusted to produce equal oxygen and pH levels
ubiquitously at the beginning of all experiments. The results suggest that temperature significantly
changes multiple components of glycolytic and mitochondrial function of all cell lines tested.
Under hypothermia conditions (32°C), the extracellular acidification rates (ECAR) of CRC cells
were significantly lower compared to the same basal ECAR levels measured at 37°C.
Mitochondrial stress test for SW480 cells at 37°C vs 42°C demonstrated increased proton leak
while all other OCR components remained unchanged (similar results were detected also for the
patient-derived xenograft cells Pt.93). Interestingly, the FCCP dose response at 37°C vs 42°C
show significant shifts in profiles, suggesting that single dose FCCP experiments might not be
sufficient to characterize the mitochondrial metabolic potential when comparing groups,
conditions or treatments.
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These findings provide valuable insights for the metabolic and bioenergetic changes of CRC cells
under hypo- and hyperthermia conditions that could potentially lead to development of better
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targeted and personalized strategies for patients undergoing combined thermotherapy with
chemotherapy.

Keywords
Cancer bioenergetics; Hyperthermia; Seahorse XF Phenograms; Hypothermia; FCCP dose
response

1. INTRODUCTION
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Thermotherapy (hyper- and hypothermia) has been utilized for the treatment of various
diseases since ancient times. One of the oldest reports describing the use of hyperthermia for
cancer dates to about 3000 BC and is found in the Egyptian Edwin Smith surgical papyrus1.
Despite centuries of research on thermotherapy, the mechanism by which this modality
produces its clinical effectiveness noted in multiple randomized clinical trials across a
spectrum of malignancies is yet unknown2. Currently, one of the main theories in the field of
temperature treatment for malignancy is that exposure to hyperthermia leads to disruption of
the mitotic cycle (G1 arrest) and apoptosis. Most experimental evidence underlying this
theory is from in vitro studies in which cell cultures were exposed to prolonged periods (24–
72 h) of hyperthermia (defined as exposure to 39° – 42°C). In a recent study, Zhu et al.,
(2015) reported that various cancer cells maintained at 39°C for 72 h demonstrated mild
inhibition of cell growth by arresting the cells at the G1 phase of the cell cycle which also
resulted in hyperthermia-enhanced efficacy of several chemotherapeutic agents3. In contrast
to the in vitro experiments, the clinical in vivo protocols typically utilize only short-term
exposure to hyperthermia. For example, several human breast cancer protocols incorporate
radiation therapy hyperthermia treatments (41–42°C) for ~60 min with at least 72 h between
individual treatment sessions4–6.
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Since the first cancer-related Seahorse XF paper7 was published in 2007, this technology has
been exponentially utilized to study cancer cell metabolism. Currently, there are more than
500 cancer related-publications on various topics but few of them focus on the use of
thermotherapy to modify cancer cell bioenergetics, metabolism and drug resistance. There is
only one previous study using Seahorse technology to investigate effects of hyperthermia on
cancer cell bioenergetics, which is focused only on basal levels of OCR. Curley et al., (2014)
used human pancreatic carcinoma cells to investigate how short term hyperthermia (cell
heated up to 46°C for 5 min) affects the base line oxygen consumption rates (OCR) when
mitochondrial function is assessed 24 hours post hyperthermia treatment on a Seahorse XF
Extracellular Flux Analyzer8. The results suggest that the 5min hyperthermia treatment
reduced OCR by approximately 50%. Total OCR levels reported represent a sum of both
non-mitochondrial respiration and base level respiration and were not normalized to cell
count or protein levels.
The goal of our study was to perform a detailed analysis of the changes in cancer cell
bioenergetics (mitochondrial and glycolytic cellular functions and their components) that
occur in real time when cells are incubated for 1 hour at temperatures equivalent to those
commonly used in clinical practice for hypo- or hyperthermia. We chose to use colorectal
Exp Cell Res. Author manuscript; available in PMC 2018 May 15.
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cancer (CRC) cells for this study because CRC have been previously reported to the final
slope of the cell survival curve where the curve approximates a straight line (aka final slope
or D0) at 43°C applied for 1.5hr and when hyperthermia is combined with mitomycin C and
cis-dichlorodiammineplatinum(II) treatment9
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The results from our study indicate that changes in temperature (shifting from 37°C to 32°C
or 42°C for period of 90–120 min) significantly alters glycolysis and, to a less extent,
modifies various components of mitochondrial function. Similar, findings has been
previously reported for yeast studies, where analysis of the high temperature-induced
glycolytic flux increasde suggested (without the use of Seahorse technology) that
hyperthermia leads to a rapid increase in glycolytic flux, which is not accompanied by an
increase in respiration10. Secondly, the study demonstrates that the Seahorse XF technology
can be successfully utilized to measure changes in cellular bioenergetics in conditions
different from normal physiological temperature of 37°C which is the standard condition for
most cancer studies. Present findings might be of significance not only for cancer research,
but also for other areas of biomedical research such as immunology, stem cells research and
many others where potentially temperature could be used to modify cellular bioenergetics.
In summary, this study provides important insights into the nature of cancer cell response to
thermotherapy, such as changes in metabolic potentials which can be potentially translated
and utilized for the development of better clinical thermotherapy protocols for cancer
treatment.

2. MATERIALS AND METHODS
2.1 Instrumentation, protocols and settings
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All experiments were performed with the Seahorse XF 96 and XF software version 1.4. This
system allows instrument temperature settings to be lowered (31–32°C) or increased (41–
42°C) for the standard duration of typical mitochondrial and glycolysis stress tests. The
maximum number of experiments completed in one day was three with increasing
temperature (the first experiment was performed at 32°C, the second at 37°C, and the final
experiment at 42°C). In a separate set of experiments, the order of temperature testing (from
42° to 37°C) was reversed to determine whether the order had any impact on the observed
results. All OCR and ECAR analyses were performed at least two times with a minimal of
6–8 technical replicates (up to 80 replicates in some cases) for each treatment or assay. All
cells were incubated for 60 min in a non-CO2 incubator before plate calibration was
performed and mitochondria and glycolysis stress test experiments were initiated at
corresponding temperature conditions.
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2.2 Cell lines
The human colon CRC cell lines, SW480 and HCT116, were obtained from ATCC
(Manassas, Virginia) and authenticated in February 2016 (Genetica DNA Laboratories,
Cincinnati, OH). All cell lines were grown in DMEM media containing 10% fetal bovine
serum (FBS), 25mM Glucose and 1mM Pyruvate. At the time of experimentation, cells were
in a passage range of 15–20 and cell seeding was 30,000 cells per well.

Exp Cell Res. Author manuscript; available in PMC 2018 May 15.
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Following appropriate approval by the Institutional Review Board (IRB) at the University of
Kentucky, CRC tissues were collected after surgical resection and implanted into NSG™,
NOD scid gamma mice (The Jacksons laboratory) to established the patient-derived
xenograft (PDX). The resultant primary CRC cell line (Pt. 93) was established after three
sequential generations in NSG mice and authenticated as a unique human cell line in
February 2016 (Genetica DNA Laboratories, Cincinnati, OH). For all of the Seahorse
experiments, Pt.93 cells were seeded at 30,000 per well in DMEM media containing 10%
FBS.
2.3 Mitochondrial stress tests
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The calibration step for all assays was completed within 15 min of loading each plate and no
additional equilibrations steps were used to minimize chances for prolonged exposure to
hypo- or hyperthermia. The instrument was programmed for 3 cycles of drug injection
followed be 3 mixing and 3 measuring steps (3 min each). Total experimental time was ~110
min. The assay media for oxygen consumption rate (OCR) experiments was DMEM-based
XF modified media containing 25mM glucose and 1mM pyruvate (pH was adjusted to 7.40
± 0.05 at 32°, 37° and 42°C accordingly).
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Three drugs were injected during the course of the assays as shown on Fig 4A: 1) Port A –
1.00 μM oligomycin A, an inhibitor of mitochondrial membrane adenosine triphosphate
(ATP) synthase (i.e., F1F0 ATP synthase or Complex V); 2) Port B – 0.3 μM FCCP Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone, an ionophore uncoupler of
oxidative phosphorylation in mitochondria that disrupts ATP synthesis by transporting
protons across cell membranes; and 3) Port C – 1.0 μM antimycin A, which inhibits the
mitochondrial electron transport chain from cytochrome b to cytochrome C1 and 1.0 μM
Rotenone, an inhibitor of mitochondrial electron transport at nicotinamide adenine
dinucleotide: ubiquinone oxidoreductase in Complex I.
2.4 Glycolysis stress tests
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The glycolysis stress test was performed under similar conditions as the mitochondrial stress
test but with few important differences. The assay media contained no glucose or pyruvate
(2mM GlutaMAX Supplement was present as part of the stock XF media ingredients). The
protocol included 4 measurements for each portion of the experiments (base line and data
points between drug injections); the duration of the experiment was approximately 110 min
(Fig 5A) and total time for the experiment ~135 min. The additional measurements were
required to reach the maximum response signal after drug injection. The drug concentrations
used during glycolysis stress tests were: 1) Port A – 10.0 μM glucose; 2) Port B – 1.0 μM
oligomycin A; and 3) Port C – 100 μM 2-deoxy-D-glucose (2-DG), a non-metabolizable
glucose analog that inhibits glycolysis.
2.5 Plate group design, background wells and protein level detection
The first and last columns of each plate (a total of 16 wells) were cell-free with 175μL of the
assay media. The empty wells were used to control for any change from baseline level in
oxygen and pH during OCR and ECAR measurements, and were also used for the
determination of protein level.

Exp Cell Res. Author manuscript; available in PMC 2018 May 15.
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2.6 Data analysis and statistics
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When data collection was complete, the media from all wells was carefully removed and
replaced with 25 μL of cell lysis buffer containing 0.32 M sucrose, 2 mM EDTA, 2 mM
EGTA, 20 mM HEPES, 0.2 mM PMSF, 4 μg/ml leupeptin, 4 μg/ml pepstatin and 5 μg/ml
aprotinin. The plates were incubated in a −20°C freezer overnight then brought to room
temperature on an orbital shaker for further processing. Increasing volumes (1.25 to 12.5 μL)
of known protein standard (2 μg/ μL BSA) were added to the background lanes to create a
standard curve for the protein levels (ranging from 2.5 to 25 μg). Thermo Scientific Pierce
BCA Protein Assay Kit was used for preparing the developing solution (mixing 4.9ml of
Reagent A + 0.1ml of Reagent B) and end volumes were total to 125 μL (25uL of sample
containing protein + 100uL of BCA Protein Assay mix. The XF Plates with protein standard
and samples were incubated at room temperature for 15 min. Seahorse XF cell plates are not
compatible with many plate readers; therefore, the content of each well was moved to a
regular-sized 96 well plate for detection of optical densities. An iMark Microplate
Absorbance Reader (BioRad) was used to detect absorbance for both standard and samples
according to the recommended detection settings for the BCA assay kit.

3. RESULTS

The Seahorse XF 96 instrument was controlled by Seahorse software (version 1.4.2.3) .XFD
data files. Seahorse Wave software (version 2.2.0) was used for further processing, including
detection of outliers and creation of base line phenograms. Automated data analysis for the
OCR and ECAR signals were performed with the help of XF Stress Test Report Generators
V2. Figures and statistical analysis were generated with GraphPad Prism version 6.05.
Statistical analysis included Welch’s t-test (or unequal variances t-test) and one-way
ANOVA followed by Dunnett’s multiple comparisons test when statistically appropriate.
Area under the curve (AUC) analysis was performed using standard buit-in analysis tool of
Prism 6.0 software (XY analysis AUC) with settings for baseline to be equal to zero for
normalized to protein SRC and baseline set up to equal to 100 for the %SRC analysis.

3.1 Base line energy phenotypes of SW480 CRC cells at 3 different temperatures

Author Manuscript

The initial experiments were performed using SW480 CRC cells incubated in a non-CO2
incubator set at 32°C, 37°C and 41°C for 60 min within 175uL per well XF modified
DMEM media containing 25mM glucose and 1mM pyruvate. After the incubation the base
line OCR and ECAR levels were measured using the Seahorse and no statistical differences
was found between OCR normalized to protein levels for the three different temperature
conditions. However, the normalized to protein ECAR levels were significantly different for
the 37°C vs. 32°C (P=0.0093, one-way ANOVA, Holm-Sidak’s multiple comparisons test)
and for the 37°C vs. 42°C conditions (P < 0.0001, one-way ANOVA, Holm-Sidak’s multiple
comparisons test) (Fig. 1A). One possible explanation for such temperature-dependent shift
in the ECAR signal could be related to the oxygen levels in the media. However, analysis of
the oxygen levels (O2 mmHg) in the media from background wells (Fig. 1B) demonstrated
that there were no differences in oxygenation during the basal level measurements (one-way
ANOVA with Bonferroni’s multiple comparisons test P=0.5606 for the 37°C vs. 32°C and
P> 0.9999 for the 37°C vs. 41°C). The average protein levels were measured at the end of
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these initial Seahorse experiments (Fig. 1C) and levels were highest in the 37°C group while
both high and low temprture treatment had lower levels of proten.
3.2 Base line energy phenotypes and OXPHOS potentials in simulated hypothermia
conditions

Author Manuscript

Next, we investigated whether the reduction of ECAR base levels at lower temperature was
unique for SW480 CRC cells or if other CRC cell lines have a similar response to changes
temperature for 1 hour. Two additional CRC cell lines (HCT116 and pt.93) were subjected to
standard mitochondrial stress tests with FCCP concentrations of 0.3μM for all tested cell
lines. The results suggested a similar shift in the baseline phenograms (Fig. 2A, B and C) as
initially observed in the SW480 cell line (Fig 1A). All baseline bioenergetic phenotypes
were calculated from the third baseline measurement (before Oligomycin was injected to
produce 1μM final concentration in each well) and results were normalized to protein levels
for each plate to reduce variability between conditions that might be due to increased/
reduced growth rates. All tested CRC cell lines had significantly lower ECAR levels at
hypothermia level temperatures compared to 37°C (unpaired t test with Welch’s correction
SW480 P< 0.0001, pt.93 P=0.0042 and HCT116 P=0.0076). There were no significant
changes in %OCR profiles (Fig. 3A, B and C), with exception to the magnitude of response
to injected 0.3 μM FCCP which could be used to calculate the spare respiratory capacity also
as percent change from base line or %SRC (Fig. 3D) the is presented as percent change of
baseline.
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Interestingly, two cell lines (SW480 and HCT116) had a decrease in %SRC while the pt.93
cell line had statistically significant increased metabolic potential (P=0.003, unpaired t-test
with Welch’s correction, n= 8–16). All mitochondrial stress test experiments for this section
were performed under the same protocol, including injection of 0.3 μM FCCP, therefore the
dose of the mitochondrial uncoupler FCCP was not optimized for individual cells shown in
Fig. 3D.
3.3 Hyperthermia effects on FCCP dose response profiles of SW480 CRC cells

Author Manuscript

Based on the different trends observed in Fig. 3D, we hypothesized that changes in
temperature may induce changes in the dose-response profiles for FCCP. To test this
hypothesis, a full FCCP dose-response study was performed with the SW480 cell line at
normal temperatures and hyperthermia. The results (Fig. 4C & D) confirmed that
hyperthermia caused shifts in the FCCP dose-response spare respiratory capacity (SRC)
profiles. It has appeared as an hyperthermia-related decrease in SRC at 0.3 μM FCCP was
only a trend at the narrow peak (marked with two vertical lines on Fig. 4C & D) of
maximum values, while the area under the entire FCCP dose range indicated an increase of
SRC with hyperthermia. Analysis of area under the curves (AUC) shows that at 42°C the
cells have almost a 32% increase of their “overall” respiratory capacity vs the 37°C
condition. Such an increase in %SRC over the range of different doses of FCCP indicated an
increased capacity of cells to meet energy demands in stress conditions.
The proton leak was the only component of the OCR signal that was statistically different
(P=0.0359, unpaired t-test with Welch’s correction, n=60–66) at higher temperatures (Fig.
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4B) suggesting that temperature might have an effect on the mitochondrial inner membrane
integrity independent of ATP synthase activity which was unchanged by temperature.
3.4 Hyperthermia effects on Glycolysis and it components of SW480 CRC cells
The SW480 cell line, used for the first round of experiments detecting base level phenotypes
and FCCP dose response curves, was also subjected to a standard glycolysis stress test under
normal and hyperthermia conditions (Fig. 5). The results show that all components of
glycolysis (Fig. 5A, D) were significant increased (P≤0.0001, unpaired t-test with Welch’s
correction, n=69–77), suggesting that glycolytic aspect of cancer bioenergetics is much more
affected under hyperthermia conditions than mitochondrial respiration components. These
biological changes were confirmed to be independent from the pH (Fig. 5B).
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Additionally, the results of glycolysis stress tests, in which cells are deprived of glucose and
pyruvate for 1h, indicated that hyperthermia-treated cells did not consume as much oxygen
as those maintained at 37°C when 10 mM glucose was added to the media (Fig. 5C). This
finding suggests that hyperthermia does not simply cause an increased total energy
metabolism, but rather a more specific shift in cancer bioenergetics and substrate preference
that requires further investigation.
The order by which the experiments were performed (starting at 37°C or 42°C) did not
affect the results due to cell growth since OCR and ECAR values were normalized to the
total protein level (μg of protein per well).
3.5 Hyperthermia effects on FCCP dose response profiles of Pt. 93 CRC cells
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Based on the different trends observed in Fig. 3D, we hypothesized that changes in
temperature may induce opposite changes in the dose-response profiles for FCCP for the Pt.
93 cell line. To test this hypothesis, a full FCCP dose-response study was performed with the
Pt. 93 cell line following same protocol as for the SW480 cells. The results (Fig. 6C & D)
confirmed that hyperthermia caused shifts in the FCCP dose-response spare respiratory
capacity (SRC) profiles but in different direction of changes observed for SW480.
Analysis of area under the curves (AUC) shows that at 42°C the Pt. 93 cells had almost a
40% decrease of their “overall” respiratory capacity vs the 37°C condition.
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Another interesting observation was that similarly to the SW480 cells, the Pt. 93 had no
significant changes in any of the mitochondrial components (Fig 6B). Again the only
component of Mitochondrial respiration that was affected was proton leaks and it was
significantly increased at the higher temperature (P<0.0001, unpaired t-test with Welch’s
correction, n=65–66).

4. DISCUSSION
In this study, we investigated changes in the bioenergetics of colorectal cancer (CRC) cell
lines as a result of temperature exposures similar to current clinical protocols. This is the
first study utilizing the Seahorse XF technology to investigate temperature-induced changes
in cancer cell bioenergetics in which cancer cells were exposed to 32°C, 37°C and 42°C for
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60 min and mitochondrial and glycolysis stress tests performed. However, it is important to
note that despite of advantages in new technology it has been long ago suspected and shown
that temperature could have significant impact on the cellular metabolism11.
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The rationale for using Seahorse XF approach is based on the fact that currently there is a
gap between the clinical duration of the hyperthermia (typically limited only 1–2 h
exposure12) and the in vitro cell line studies where hyperthermia periods are much longer or
variable. The cancer literature reports use of different protocols involving exposure of cell
lines to hyperthermia from 1 hour13 up to 3 days3, and some cases up for 2 weeks14 (in most
cases 12–36 h) which makes difficult to draw direct parallels between possible molecular
mechanisms underlying the in vitro results and the outcomes of the human hyperthermia
clinical studies. The Seahorse extracellular flux analyzer has been reported to produce
valuable data measuring cancer metabolism under different experimental conditions
including, but not limited to the following: testing effects on novel therapies15–17, changes in
cancer cell substrate preferences18–20, effects of gene overexpression or knockdown in
cancer cells21–23, effects of hypoxia20, 24 and cell environmental factors25–27.
This is the probably the first report documenting that changes in the temperature of CRC
cellular environment have a significant impact on cancer glycolysis even if oxygen levels are
unchanged. Notably, while hyperthermia significantly affects all aspects of glycolysis (Fig.
5D) it seems to have a little effect on oxidative phosphorylation (Fig. 4B). These results
suggest that hypo- or hyperthermia treatments may potentially be used to modify the
glycolytic metabolism of cancer cells while components of mitochondrial function such as
basal level respiration and ATP production remain unaffected by temperature.

Author Manuscript

The results of the mitochondrial and glycolysis stress tests under hyperthermia conditions
show an increase of both SRC profiles (Fig. 4C) and glycolytic reserve (Fig. 5D) in SW480
CRC cells. In general, SRC is an indicator of metabolic plasticity or the ability of a cell to
meet an increased energy demand28. A recent study in cardiac myocytes demonstrated that
the main source of the spare/reserve capacity is the mitochondrial complex II, which, by
activation of metabolic sensors including pyruvate dehydrogenase and AMP-dependent
kinase, increases the respiratory capacity via a Sirtuin 3 (Sirt3)-dependent mechanism29. A
similar pathway for modification of SRC may also exist in cancer cells, but it is yet unclear
how temperature alters the metabolic enzymes toward an enhanced SRC.

Author Manuscript

One potential mechanism utilized by cancer cells and observed in this study may be the
change in their dose-response profiles with an increased production of exosomes. A recent
study showed that when cancer cells are treated with anticancer drugs such as Doxorubicin
(Dox), the cells use exosomes to remove Dox from cytosol and when heat stress is applied
the process of drug removal by exosomes intensifies30. However, if this exosome theory is
true for FCCP it is logical to suspect that the other drugs (i.e. Oligomycin, Rotenone and
Antimycin) used in a standard Seahorse mitochondrial stress test also might be subjected to
the action of exosomes.
Another possible mechanism for changes observed in the differential sensitivity to FCCP
between SW480 and Pt. 93 cells could be based on temperature effects on membrane
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potential. Several studies in the past have shown that temperature could impact membrane
barrier function in in isolated heart and liver mitochondria31, and in intact breast cancer
cells32 which also might explain the proton leak results. Furthermore, as explanation for the
proton leak results could be find in potental increased expression of UCP2, which is often
found characteristic feature of various tumors33, 34.
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The experimental results (Fig. 4D) suggest there is no difference in the outcome OCR signal
if the same doses (1.0 μM final in the wells) are applied at different temperatures. This result
could be due to cells being less sensitive to the doses of Oligomycin, Rotenone and
Antimycin compared to the FCCP. In fact, it is highly recommended that an FCCP doseresponse is performed for every Seahorse experiment to optimize uncoupling results. The
suggested concentrations for all other drugs (used for mitochondria and glycolysis stress
test) rarely need any titration or dose optimization under most experimental conditions and
cell lines. In most cases when researchers report experimental results for mitochondrial
maximum respiration and SRC the results are represented as an outcome of a single FCCP
dose study. Single dose FCCP studies may actually represent a narrow snapshot compared to
the larger range of FCCP doses. For example, Fig. 4D shows that the maximum FCCP
response is at a concentration of 0.3μM. In addition, Fig. 4D shows, on ascending and
descending sides, a higher %SRC value for 37°C initially and a higher %SRC for 42°C with
an increasing dose of FCCP. When the differences in FCCP dose responses were evaluated
as an area under the curve calculation, the range of doses for the 42°C condition clearly
indicated better metabolic plasticity, or the ability to meet an increased energy demand.

Author Manuscript

Another theory that may explain the outcomes of hyperthermia in cancer therapy is
chromosomal fragmentation during hyperthermia treatment. Such fragmentations have been
reported to cause mitotic cell death, distinct from apoptosis and other mitotic arrests or
catastrophes; however, this process seems to occur most in cell cultures grown at high
temperatures for an extended period of time (42°C for days or weeks)14. An additional
hypothesis more relevant to clinical protocols is that a short term hyperthermia treatment is
effective as an anti-cancer treatment due to a temperature-dependent activation of the
immune system involving mechanisms that include increasing vascular perfusion,
lymphocyte trafficking, inflammatory cytokine expression, tumor cell metabolism, and
innate and adaptive immune functions35. Additionally, exosomes are known as structures
that also mediate cancer cell resistance to drugs36; however, little is known about the effects
of hyperthermia on cancer exosomes.
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Increases (or decreases/exhaustion) of the spare respiratory and glycolytic capacities are
known to play an important role in a variety of pathologies including heart diseases 37,
neurodegenerative disorders38, 39, immunity40, 41 and muscle function42, 43. The results of
this study show that thermotherapy can be used to modify the metabolic capacity of cancer
cells and this finding opens several new avenues for future research in cellular bioenergetics
based on temperature interventions. The main limitation of this study is that it provides only
a functional description of changes in cancer bioenergetics without investigating the
mechanistic details for the molecular components or cell signaling pathways involved in the
bioenergetic changes observed at high and low temperatures. The scope of this study was to
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provide functional information about cell bioenergetics under thermal stress and lay the
groundwork for future studies in the mechanisms underlying these observations.
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The glycolysis tests determined that hyperthermia causes a significant increase in glycolytic
reserve (Fig. 5D). There are two accepted directions in the search of novel agents and
oncologic therapeutic regimens: 1) to modify the cancer cells’ characteristics and phenotype
to shift toward a less glycolytic profile and move cell metabolism toward a normal noncancer cell bioenergetic profile and 2) to push the cells toward greater glycolysis, and find
targets and drugs that will inhibit the glycolysis, which on a systemic level will have less
impact for normal cells. However, the second modification will have more injurious effect
for cells that are highly dependent on glycolysis. It is known that in normal cells activation
of the oncogenic signaling pathways such as PI3K/Akt/mTOR, c-Myc, and Ras leads to an
increased glucose uptake and a high glycolytic activity similar to the Warburg effect in
cancer cells44. It has been reported that these characteristics of cancer cells can be
successfully exploited to bypass the problem of systemic toxicity of antiglycolytic agents45.

5. CONCLUSIONS

Author Manuscript

This study introduces new concepts that extend clinical and translational interests in the
search of better multimodal oncologic therapies. Most importantly, hyperthermia results
show increases in all aspects of glycolytic cellular function and less significant changes in
OXPHOS. Short-term hypothermia increases both glycolic capacity and mitochondrial spare
respiratory capacity in the tested cancer cells, which theoretically should have impact also
on cellular resistance to chemotherapy. Clinical studies indicate that hyperthermia could
successfully enhance chemotherapy are likely due to immune activation effects of
hyperthermia. The present study also provides evidence that temperature changes can
modulate colorectal cancer cells metabolism, thus potentially affecting treatment outcome.
Moreover, we demonstrate that a real time, in a microplate, label-free detection technology
can be effectively used to study complex aspects of oncologic bioenergetics in the future
studies.
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Figure 1. Baseline energy profiles and oxygen levels
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(A) OCR and ECAR levels of SW480 cell line incubated for approximately 60 min in XF
modified media containing 25mM glucose and 1mM pyruvate. No statistical differences
were found between OCR normalized to protein levels for the three different temperature
conditions. The normalized to protein ECAR levels were significantly different for the 37°C
vs. 32°C (P=0.0093, one-way ANOVA, Holm-Sidak’s multiple comparisons test, n=14–16)
and for the 37°C vs. 42°C conditions (P < 0.0001, one-way ANOVA, Holm-Sidak’s multiple
comparisons test, n=14–16); (B) Oxygen levels (mmHg) at the base-line time were not
statistically different between temperature conditions. Oxygen levels shown represent
control wells containing media alone without cells; (C) Protein levels were determined at the
end of the experiments with BCA assay (n=8–16). One-way ANOVA with Bonferroni’s
multiple comparisons test show no significant differences between 37°C and 41°C
(P=0.2828) and decreased in protein levels for the 32°C group compared to 37°C
(P=0.0020).
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Figure 2. Raw and normalized to protein base line phenograms for 3 different colon cancer cell
lines

(A) Base line phenograms for SW480 show significant differences in both Glycolysis
(ECAR) and Mitochondrial Respiration (OCR) at the third base line data point while
bioenergetics data have not been normalized to protein (n=8–16). Please note: The
quadrants have been set at arbitrary values only to indicate direction of bioenergetic changes
for cells and treatments; (B) Base line phenograms for Pt. 93 show significant differences in
both Glycolysis (ECAR) and Mitochondrial Respiration (OCR) when data is not normalized
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to protein (n=8–16); (C) Base line phenograms for HCT116 show significant differences in
both Glycolysis (ECAR) and Mitochondrial Respiration (OCR) when data is not normalized
to protein (n=8–16). Also the 37°C group of HCT116 seems to be more quiescent compared
to the other two cell lines at 37°C; (C) Protein levels were significantly lower at 32°C
compared to 37°C (P values were ≤0.0001 for all cells, one-way ANOVA, Holm-Sidak’s
multiple comparisons test, n=13–16); (E) Pt. 93 cells data was normalized to protein level
and ECAR and OCR were both significantly lower at 32°C (P=0.0042 and P=0.0047,
respectively, unpaired t-test with Welch’s correction, n=14–15); (F) HCT 116 cell line also
had a lower baseline ECAR phenotype for the 32°C vs 37°C conditions (P=0.0076, unpaired
t-test with Welch’s correction, n=16) and no statistical difference for the OCR.
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Figure 3. Mitochondria stress test profiles and SRC as percent change of base line for 3 different
colon cancer cell lines at hypothermia condtions
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(A) SW480 cell profile (n=8–16), OCR profiles were converted to % change OCR from of
third base-line data point (which was set to be 100% for all wells); (B) Pt. 93 cells (n=8–16)
%OCR profiles; (C) HCT116 cells (n=8–16) %OCR profiles; (D) Analysis of percent
change of spare respiratory capacity (%SRC) in response to hypothermia show that two of
the cell lines (SW480 and HCT116) had a statistically significant decrease (P<0.0001,
unpaired t-test with Welch’s correction, n=8–16) at lower temperature and one cell line (pt.
93) had significant increase (P=0.003, unpaired t-test with Welch’s correction, n=8–16).
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Figure 4. Mitochondria stress test for SW480 at normal and high temperatures and FCCP dose
response
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(A) The “raw” (not normalized to protein) 37°C SW480 OCR profile at 0.3 μM FCCP was
used to illustrate the various components of the mitochondrial function. (B) Quantification
of the temperature difference in SW480 OCR components that are independent of FCCP
concentrations. Proton leak was significantly increased (P= 0.0359, at the higher unpaired ttest with Welch’s correction, n=60–66) at the higher temperature, while all other
components remained without significant changes. (C) The changes in the SRC, due to
various FCCP doses at 37°C, were less prominent compared to the 42°C. (AUC analysis
shows a 32% increase of the “overall” respiratory capacity at 42°C vs the 37°C condition.)
(D) The analysis of AUC for %SRC was limited to the baseline, and at 42°C the cells had
~21% higher “overall” metabolic potential.
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Figure 5. Glycolysis stress test for SW480 cell at normal and high temperatures
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(A) SW480 ECAR profile components presented over the experimental record from 42°C
vs. 37°C. (B) There was no statistically difference in pH levels in background wells during
the measurement of the baseline ECAR signals. (C) The percent change of oxygen
consumption rates during the glycolysis stress test indicated that after adding 10μM Glucose
the cells at 37°C consumed more oxygen compare to the cells at 42°C. (D) The unpaired ttest with Welch’s correction of ECAR signal components suggests that all aspects of
glycolysis were significantly increased at the higher temperature: Non-glycolytic
Acidification (P=0.0002, n=69–77); Glycolysis (P<0.0001, n=69–77); Glycolytic Capacity
(P<0.0001, n=69–77) and Glycolytic Reserve (P<0.0001, n=69–77).
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Figure 6. Mitochondria stress test for Pt. 93 at normal and high temperatures and FCCP dose
response
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(A) The “raw” (not normalized to protein) 37°C Pt. 93 OCR profile at 0.3 μM FCCP was
used to illustrate the various components of the Pt. 93 mitochondrial function. (B)
Quantification of the temperature difference in Pt. 93 OCR components that are independent
of FCCP concentrations. Proton leak was significantly increased (P<0.0001, unpaired t-test
with Welch’s correction, n=65–66) at the higher temperature, while all other components
remained without significant changes. (C) The changes in the SRC, due to various FCCP
doses at 37°C, were more prominent (unlike the SW480) compared to the 42°C. (AUC
analysis shows a 39% increase of the “overall” respiratory capacity at 37°C vs the 42°C
condition.) (D) The analysis of AUC for the %SRC was limited to the baseline, and at 42°C
the cells had ~40% lower “overall” metabolic potential.
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